Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Debt to Equity (2020 - 2025)

GeneDx Holdings has reported Debt to Equity over the past 6 years, most recently at $0.16 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.16 for Q4 2025, down 26.15% from a year ago — trailing twelve months through Dec 2025 was $0.16 (down 26.15% YoY), and the annual figure for FY2025 was $0.16, down 26.15%.
  • Debt to Equity for Q4 2025 was $0.16 at GeneDx Holdings, down from $0.18 in the prior quarter.
  • Over the last five years, Debt to Equity for WGSWW hit a ceiling of $0.27 in Q2 2024 and a floor of -$0.04 in Q1 2021.
  • Median Debt to Equity over the past 5 years was $0.04 (2022), compared with a mean of $0.11.
  • Biggest five-year swings in Debt to Equity: soared 1173.55% in 2024 and later crashed 30.64% in 2025.
  • GeneDx Holdings' Debt to Equity stood at $0.04 in 2021, then rose by 10.53% to $0.04 in 2022, then surged by 495.59% to $0.23 in 2023, then dropped by 8.39% to $0.21 in 2024, then decreased by 26.15% to $0.16 in 2025.
  • The last three reported values for Debt to Equity were $0.16 (Q4 2025), $0.18 (Q3 2025), and $0.19 (Q2 2025) per Business Quant data.